Immix Biopharma, Inc.

[email protected]
(888) 958-1084
2216 Linnington Avenue, Los Angeles, CA 90064
Pharmaceutical Companies
Business: Pharma & Medical Devices
back to directoryBack to Directory

Related Posts:

IMMIX BIOPHARMA, INC.: Immix Receives FDA Authorization to Expand Clinical Trial under US IND
IMMIX BIOPHARMA, INC.: Immix Receives FDA Authorization to Expand Clinical Trial under US IND

July 26, 2019

Immix receives FDA letter activating the IND for IMX-110

Read more →

Trending

BAYER: U.S. FDA Approves Addition of Overall Survival and Other Secondary Endpoint Data to NUBEQA® (darolutamide) Prescribing Information
LOCATE BIO: CognitOss Granted FDA Breakthrough Device Designation
NORTHSTAR MEDICAL RADIOISOTOPES: Announces FDA Approval for Enhanced U.S. Mo-99 Radioisotope Production Capacity
KING & SPALDING: FDA and Life Sciences Team Adds Partner in Washington
FUNCTIONAL NEUROMODULATION: Announces Breakthrough Device Designation from the U.S. FDA for Deep Brain Stimulation for Alzheimer’s Disease
ULTROMICS: Receives Fda Clearance for a First-of-kind Solution in Echocardiography to Help Clinicians Diagnose Disease

The Weekly Newsletter

Sign-up for the Weekly Newsletter from FDA Reporter.